Yongfang Z. Gong
Key Laboratory Of Anti Inflammatory And Immunopharmacology
Hefei, 230032, China
Hefei, 230032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Inhibition of MST1/2 attenuates the anti-hepatocarcinogenesis effect of Salvianolic acid B via the ERK/MAPK signaling pathway.
Journal: European journal of pharmacology
Published: December 31, 2025
Gambogic acid ameliorates hepatocellular carcinoma by inhibiting oxidative stress via Nrf2-pSmad2C/2L pathway.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 18, 2025
Salvianolic acid B targets MST1/2-YAP axis to drive phospho-Smad3L/C conversion against hepatocarcinogenesis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 13, 2025
Salvianolic acid B ameliorates hepatic fibrosis via inhibiting p300/CBP.
Journal: European journal of pharmacology
Published: August 06, 2024
Nrf2 knockout attenuates the astragaloside IV therapeutic effect on kidney fibrosis from liver cancer by regulating pSmad3C/3L pathways.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 29, 2023
Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously.
Journal: European journal of pharmacology
Published: August 03, 2022
Role of Bruton's tyrosine kinase in endotoxin/lipopolysaccharide-induced pyroptosis of intestinal cells in scalded mice
Journal: Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns
Published: June 18, 2021
Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Journal: Journal of ethnopharmacology
Published: April 28, 2021
Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 25, 2021
Smad3 C-terminal phosphorylation site mutation attenuates the hepatoprotective effect of salvianolic acid B against hepatocarcinogenesis.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: August 05, 2020
Sorafenib suppresses proliferation rate of fibroblast-like synoviocytes through the arrest of cell cycle in experimental adjuvant arthritis.
Journal: The Journal of pharmacy and pharmacology
Published: July 25, 2020
Activation of Nrf2/AREs-mediated antioxidant signalling, and suppression of profibrotic TGF-β1/Smad3 pathway: a promising therapeutic strategy for hepatic fibrosis - A review.
Journal: Life sciences
Published: March 02, 2020
Last Updated: 09/26/2026